NCT00112983View on ClinicalTrials.gov

Eculizumab in Treating Patients With Paroxysmal Nocturnal Hemoglobinuria

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 2004

Study Completion Date

June 30, 2005

Conditions
Leukemia
Interventions
BIOLOGICAL

eculizumab

Trial Locations (1)

90095-1678

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles

All Listed Sponsors
lead

Jonsson Comprehensive Cancer Center

OTHER

NCT00112983 - Eculizumab in Treating Patients With Paroxysmal Nocturnal Hemoglobinuria | Biotech Hunter | Biotech Hunter